FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3136126035> ?p ?o ?g. }

• W3136126035 endingPage "24" @default.
• W3136126035 startingPage "15" @default.
• W3136126035 abstract "Objective — to investigate the dynamics of life quality in patients with pulmonary tuberculosis against the background of the appointment of an essential amino acids complex.&#x0D; Materials and methods. The study included 100 patients with pulmonary tuberculosis who received treatment and diagnosis in accordance with the WHO recommendations and current state protocols. The patients were divided into 3 groups: group 1 (n = 50) did not receive additional complex of amino acids in pathogenetic therapy; group 2 (n = 25) received a complex of amino acids in tablet form for 30 days; group 3 (n = 25) received injectable amino acids complex for 10 days and then was transferred to tablet form for 20 days. At the beginning of treatment, after 30 days and after 60 days, the patients were interviewed using the SF-36 questionnaire. Also, the patients were measured the level of Human-beta-defensine-1 in the blood plasma by ELISA at the beginning of treatment.&#x0D; Results and discussion. After 30 doses of anti-tuberculosis treatment, better quality of life parameters were observed in groups 2 and 3 than in group 1. Thus, the PF in group 1 was 54.73 ± 2.99, in group 2 — 80.87 ± 2.82, in group 3 — 66. 4.23; RP was in group 1 — 20.27 ± 3.47, in group 2 — 81.52 ± 3.92, in group 3 — 55.00 ± 7.07; GH was 16.68 ± 1.79 in group 1, 45.48 ± 3.09 in group 2, 34.04 ± 3.35 in group 3; VT was in group 1 — 13.38 ± 1.55, in group 2 — 45.87 ± 2.86, in group 3 — 33.60 ± 3.68; SF was 43.45 ± 2.39 in group 1, 69.02 ± 2.06 in group 2, and 60.50 ± 3.53 in group 3; RE was in group 1 — 27.03 ± 4.80, in group 2 — 95.65 ± 3.18, in group 3 — 73.33 ± 7.69; MH was in group 1 — 39.22 ± 1.36, in group 2 — 60.00 ± 2.12, in group 3 — 56.00 ± 2.71, p < 0.05. This ratio between the groups remained at 60 doses of chemotherapy: PF was 62.17 ± 3.47 in group 1, 82.95 ± 2.39 in group 2, and 76.52 ± 3.42 in group 3; RP in group 1 was 28.33 ± 4.90, in group 2 — 90.91 ± 3.09, in group 3 — 66.30 ± 7.14; GH was 22.97 ± 2.13 in group 1, 52.63 ± 3.14 in group 2, 46.78 ± 4.22 in group 3; VT was 19.33 ± 1.91 in group 1, 50.68 ± 2.72 in group 2, and 40.87 ± 3.98 in group 3; SF was 50.67 ± 2.31 in group 1, 75.00 ± 2.18 in group 2, and 68.48 ± 3.84 in group 3; RE was 36.67 ± 6.26 in group 1, 98.49 ± 1.52 in group 2, 82.61 ± 6.91 in group 3; MH was 42.73 ± 1.62 in group 1, 63.82 ± 2.01 in group 2, 59.83 ± 2.75 in group 3, p < 0.05.&#x0D; Conclusions. The appointment of a complex of amino acids as an additional pathogenetic therapy in patients with pulmonary tuberculosis improves the quality of life, and the appointment of an injectable form of amino acids accelerates patients’ adaptation and increases adherence to treatment, which is one of the key factors in the effectiveness of therapy." @default.
• W3136126035 created "2021-03-29" @default.
• W3136126035 creator A5029313243 @default.
• W3136126035 creator A5049158077 @default.
• W3136126035 date "2021-03-23" @default.
• W3136126035 modified "2023-09-25" @default.
• W3136126035 title "Dynamics of life quality in patients with pulmonary tuberculosis against the background of the appointment of an essential amino acids complex" @default.
• W3136126035 cites W2005335283 @default.
• W3136126035 cites W2007679273 @default.
• W3136126035 cites W2017024005 @default.
• W3136126035 cites W2019411946 @default.
• W3136126035 cites W2067214964 @default.
• W3136126035 cites W2082713145 @default.
• W3136126035 cites W2114935674 @default.
• W3136126035 cites W2520962153 @default.
• W3136126035 cites W2529363256 @default.
• W3136126035 cites W3129076394 @default.
• W3136126035 doi "https://doi.org/10.30978/tb2021-1-15" @default.
• W3136126035 hasPublicationYear "2021" @default.
• W3136126035 type Work @default.
• W3136126035 sameAs 3136126035 @default.
• W3136126035 citedByCount "0" @default.
• W3136126035 crossrefType "journal-article" @default.
• W3136126035 hasAuthorship W3136126035A5029313243 @default.
• W3136126035 hasAuthorship W3136126035A5049158077 @default.
• W3136126035 hasConcept C126322002 @default.
• W3136126035 hasConcept C141071460 @default.
• W3136126035 hasConcept C142724271 @default.
• W3136126035 hasConcept C159110408 @default.
• W3136126035 hasConcept C185592680 @default.
• W3136126035 hasConcept C187212893 @default.
• W3136126035 hasConcept C2777785397 @default.
• W3136126035 hasConcept C2779951463 @default.
• W3136126035 hasConcept C2781069245 @default.
• W3136126035 hasConcept C2908628106 @default.
• W3136126035 hasConcept C515207424 @default.
• W3136126035 hasConcept C55493867 @default.
• W3136126035 hasConcept C71924100 @default.
• W3136126035 hasConceptScore W3136126035C126322002 @default.
• W3136126035 hasConceptScore W3136126035C141071460 @default.
• W3136126035 hasConceptScore W3136126035C142724271 @default.
• W3136126035 hasConceptScore W3136126035C159110408 @default.
• W3136126035 hasConceptScore W3136126035C185592680 @default.
• W3136126035 hasConceptScore W3136126035C187212893 @default.
• W3136126035 hasConceptScore W3136126035C2777785397 @default.
• W3136126035 hasConceptScore W3136126035C2779951463 @default.
• W3136126035 hasConceptScore W3136126035C2781069245 @default.
• W3136126035 hasConceptScore W3136126035C2908628106 @default.
• W3136126035 hasConceptScore W3136126035C515207424 @default.
• W3136126035 hasConceptScore W3136126035C55493867 @default.
• W3136126035 hasConceptScore W3136126035C71924100 @default.
• W3136126035 hasIssue "1" @default.
• W3136126035 hasLocation W31361260351 @default.
• W3136126035 hasOpenAccess W3136126035 @default.
• W3136126035 hasPrimaryLocation W31361260351 @default.
• W3136126035 hasRelatedWork W2002120878 @default.
• W3136126035 hasRelatedWork W2003938723 @default.
• W3136126035 hasRelatedWork W2010519422 @default.
• W3136126035 hasRelatedWork W2047967234 @default.
• W3136126035 hasRelatedWork W2118496982 @default.
• W3136126035 hasRelatedWork W2366490125 @default.
• W3136126035 hasRelatedWork W2418937676 @default.
• W3136126035 hasRelatedWork W2439875401 @default.
• W3136126035 hasRelatedWork W4210941341 @default.
• W3136126035 hasRelatedWork W2525756941 @default.
• W3136126035 isParatext "false" @default.
• W3136126035 isRetracted "false" @default.
• W3136126035 magId "3136126035" @default.
• W3136126035 workType "article" @default.